The Digital Source For China's Tech Innovation Since 2000

China Weighs Methods for Relaxing Zero-Covid-19 Grip: Bubbles, Drugs and New Messaging

March 3, 2022
Source: bioethics.com bioethics.com
News Snapshot:
China Weighs Methods for Relaxing Zero-Covid-19 Grip: Bubbles, Drugs and New Messaging March 2, 2022 Wall Street Journal ) – China, the last major country to stick with a zero-tolerance approach to Covid-19, is now actively exploring ways to loosen controls. In preparation for a potential opening, Chinese officials are looking into the use of travel bubbles modeled on measures taken during the Winter Olympics, collecting data on new antiviral drugs and scouting sites abroad for future production of homegrown Chinese mRNA vaccines, according to people familiar with the matter. Covid-19 controls likely won’t be eased before next spring, according...
Go To Original Source →
Tags: China | Chinese | Covid-19 | data | drugs | messaging | Olympics | production | sports | travel | Wall Street Journal

Other Related News:

Mitsubishi's former Chinese joint venture eyes RHD markets, could include Australia

May 12, 2025

India has only pressed the pause button on Pakistan. It needs serious behavioural change

May 12, 2025

Why are India and Pakistan fighting?

May 12, 2025

Local Chinese community members get behind-the-scenes look at Southlake

May 12, 2025

Scientists say this bismuth-powered chip is 40% faster than Intel’s best – are silicon processors officially finished?

May 12, 2025

Canada’s electric vehicle strategy has failed, and there are lessons to learn

May 12, 2025

SANJAYOVACHA | Wars Help Promote Sales for Military Industrial Complex

May 12, 2025

Behind the scenes with identical twins Paula and Bridgette Powers after carjacking interview

May 12, 2025

Australia's economy is a basket case again. Will Jim Chalmers take it on?

May 12, 2025
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
© 2025 ChinaTechNews.com. A Service of Asia Media Network.
Twitter